Allospecific splenic Tr1 cells drive effector T cell exhaustion through up-regulated Areg-EGFR signaling to promote transplant tolerance.

Singh, Amar; Herman, Adam; Dey, Devanjan; Menge, Samuel; Singh, Shilpi; Tran, Anna; Matson, Anders; Mourad, Ahmed et al. · Sci Adv · 2026

basic_science · Level V

Where this comes from

Abstract

Inducing stable tolerance to transplants remains a challenge in immunology. Previously, we induced tolerance to allogeneic islets in nonhuman primates by preemptive alloantigen delivery to antigen-presenting cells in situ. Here, mass cytometry phenotyping with incorporated donor-derived MHC-I peptide-loaded MHC-II tetramers revealed accumulation of allospecific CD4<sup>+</sup> T cell clusters in the spleen of tolerant recipients. Areg<sup>+</sup>Tr1 regulatory and terminally exhausted EGFR<sup>hi</sup> T (Tex) cells represented the predominant allospecific subsets. Trajectory analysis showed that antigen-experienced effector memory T cells differentiated into suppressive Areg<sup>+</sup>Tr1 and EGFR<sup>+</sup>TOX<sup>+</sup>Nur77<sup>+</sup>TCF-1<sup>-</sup> Tex subsets. Cell-cell communication mapping showed that exhausted and effector memory T cells engaged with allospecific Tr1 cells via the Areg-EGFR axis. Gene silencing studies confirmed that Tr1 cells use Areg-EGFR signaling to drive the metabolic suppression and epigenetic reprogramming of CD4<sup>+</sup> T cells through a Nur77-dependent pathway. These findings point to the splenic Areg<sup>+</sup>Tr1 cell-EGFR<sup>+</sup>Teff cell axis as a critical immunoregulatory pathway in peripheral transplant tolerance.

Medical subject headings